Quest Diagnostics
DGX
#1168
Rank
$15.25 B
Marketcap
$137.30
Share price
0.20%
Change (1 day)
-0.94%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

P/S ratio for Quest Diagnostics (DGX)

P/S ratio as of June 2024 (TTM): 1.64

According to Quest Diagnostics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.6424. At the end of 2023 the company had a P/S ratio of 1.68.

P/S ratio history for Quest Diagnostics from 2001 to 2023

PS ratio at the end of each year

Year P/S ratio Change
20231.68-7.05%
20221.80-8.37%
20211.9715.6%
20201.70-7.43%
20191.8423.16%
20181.49-16.9%
20171.805.95%
20161.7024.88%
20151.364.53%
20141.3020.39%
20131.08-14.68%
20121.263.68%
20111.22-2.46%
20101.25-15.77%
20091.485.99%
20081.40-8.56%
20071.53-6.59%
20061.64-11.83%
20051.86-1.39%
20041.8918.89%
20031.5916.92%
20021.36-28.51%
20011.90

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
1.42-13.84%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
0.6317-61.54%๐Ÿ‡บ๐Ÿ‡ธ USA
2.72 65.66%๐Ÿ‡บ๐Ÿ‡ธ USA
5.01 204.82%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
4.34 164.23%๐Ÿ‡บ๐Ÿ‡ธ USA